Quarterly Result21 May 2026, 05:31 pm
Genpharmasec Approves Audited Financial Results for FY26
AI Summary
Genpharmasec Ltd's Board of Directors approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The board also approved the re-appointment of M/s. Abhishek M Agrawal & Co. as Internal Auditor for the financial year 2026-2027. The Statutory Auditors, M/s. Bilimoria Mehta & Co., issued an audit report with an unmodified opinion on the financial results.
Key Highlights
- Audited standalone and consolidated financial results for FY26 approved.
- M/s. Abhishek M Agrawal & Co. re-appointed as Internal Auditor for FY27.
- Statutory Auditors issued an unmodified opinion on FY26 financial results.
- Board meeting commenced at 4:30 p.m. and concluded at 05:15 p.m. on May 21, 2026.
Price Impact
More from GENPHARMA
More in Quarterly Result